News

 

05.20.13
Cindy Dibiasi to Speak on Media Interview Techniques

The presentation is an In-Person Meeting with the CRN Communications & Media Outreach Committee (CMOC) on Using Message Grids For Successful Media Interviews .

Full text
04.23.13
3D's Cardiovascular Disease Advisory Board

3D Communications Announces Formation of Cardiovascular Disease Advisory Board

Full text
02.15.13
Former FDA Official Joins 3D Communications' Scientific and Regulatory Advisory Board

Andrea Leonard-Segal, MD, recent Director in the FDA Center for Drug Evaluation and Research (CDER), is appointed to Scientific and Regulatory Advisory Board position.

Full text
02.11.13
Drug Information Association Publishes 3D Communications Survey

How FDA Pharmaceutical Drug and Medical Device Advisory Committee Members Prepare and What Influences Them.

Full text
09.27.12
Drug Information Association Publishes 3D Communications Survey

How FDA Pharmaceutical Drug and Medical Device Advisory Committee Members Prepare and What Influences Them.

Full text
11.13.11
Cindy Dibiasi of 3D Communications Quoted in the October 24th Tan Sheet

Full text
10.19.11
Cindy Dibiasi of 3D Communications Quoted in The Tan Sheet

The Tan Sheet - OTC Switch "Blueprint" Could Help Regulatory Navigation - Researchers

Full text
10.15.11
Cindy Dibiasi of 3D Communications Mentioned in C. Gold Marketing Blog

The article focuses on the value of media training for marketing professionals.

Full text
10.15.11
Cindy Dibiasi of 3D Communications Quoted in The Tan Sheet

Somaxon Pharmaceuticals expects to make its Silenor sleep aid available OTC in five to seven years...

Full text
07.27.11
3D Communications Contributes to New Edition of RAPS’ Essential Regulatory Affairs Text Book

Full text
02.11.11
3D Communications Quoted in Fierce Biotech

Full text
02.11.11
3D Communications Quoted in The San Diego Union Tribune

Full text
02.08.11
Former CHPA, FDA, HHS Executive to Join 3D Communications

Virginia Cox to Broaden 3D’s Healthcare and FDA Regulatory Communications Expertise

Full text
08.09.10
The Tan Sheet

Label Comprehension Guidance May Improve Switch Outlook

Full text
06.28.10
The Tan Sheet

Six Strategies To Capitalize On Pre-Application Meetings With FDA

Full text
03.10.10
The Tan Sheet

FDA Affirms Priority For OTCs As It Combines ONP With Imaging Products

Full text
06.02.08
The Pink Sheet

Advisory Committee Vacancies Remain High As FDA Revs Up Search Efforts

Full text
05.19.08
The Tan Sheet

Prepare More Data Earlier For Advisory Panels In Era Of Low Risk-Tolerance

Full text